The database of public procurement
Company
Orifarm GmbH
Orifarm GmbH from Leverkusen has been awarded 1,393 public contracts since 2006, 1,362 of them EU-wide up to 2023 (as of 4 Oct 2026).
As of: · Source: official notices (Datenservice Öffentlicher Einkauf, CC0), EU Official Journal (TED) and procurement portals · How we count
Awards per year, 2006 to today
Up to 2023 from the EU Official Journal (only contracts above the EU thresholds), from 2024 from the Datenservice Öffentlicher Einkauf and the portals. The current year is incomplete.
Timeline, 36 months
2 more before this window.
One dot per award in the month of the notice, sized by value, red when there was only one bid. Click a dot to open the notice.
The network around Orifarm
Contracting authorities
Next door on the site
- EurimPharm Arzneimittel GmbH Saaldorf-Surheim17
- Abacus Medicine A/S Kopenhagen (DK)16
- kohlpharma GmbH Merzig16
- CC Pharma GmbH Densborn15
- axicorp Pharma B.V. Den Haag14
Contracting authorities and neighbours from the award notices, planners from the office register, brands from the bills of quantities of the tender before the award. Figures are lots.
Competitors
No one else in the database wins in these trades with the contracting authorities of this company.
Who wins with the 4 most frequent contracting authorities of this company in the same trades.
References: recently won
| Date | Lot | Contracting authority | Value | Bids |
|---|---|---|---|---|
| 23 Sep 2026 | Siehe im Feld "Allgemeine Informationen"Other · Source (Procurement portal) | Techniker KrankenkasseHamburg | ||
| 15 Sep 2026 | C1-Esterase-Inhibitor, human 1.500 E. in 3 ml Fertiglsg. Pulver u. Lösungsmittel zur Herstellung einer Injektionslsg. StOther · Source (Procurement portal) | PBMG eG | 2 | |
| 31 May 2026 | 7d892fe9-2f72-4210-bcf9-ecfe177e5133 · Source (Procurement portal) | not in the index | ||
| 31 May 2026 | 7d892fe9-2f72-4210-bcf9-ecfe177e5133 · Source (Procurement portal) | not in the index | ||
| 31 May 2026 | 7d892fe9-2f72-4210-bcf9-ecfe177e5133 · Source (Procurement portal) | not in the index | ||
| 31 May 2026 | de3bea49-bb1e-4041-98c9-aed214036f81 · Source (Procurement portal) | not in the index | ||
| 5 Mar 2026 | 6395e86c-e2f5-458a-ae8f-dd9db9a395aa · Source (Procurement portal) | not in the index | ||
| 5 Mar 2026 | 6395e86c-e2f5-458a-ae8f-dd9db9a395aa · Source (Procurement portal) | not in the index | ||
| 4 Mar 2026 | 46dd758e-308c-4435-8a8d-9c063ccdb4cf · Source (Procurement portal) | not in the index | ||
| 4 Mar 2026 | 46dd758e-308c-4435-8a8d-9c063ccdb4cf · Source (Procurement portal) | not in the index | ||
| 1 Feb 2026 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Progesteron (ausschl. Dafo. WKA), ATC G03DA04 für die Zeit 01.02.26 - 31.01.28 (zzgl. V.-Option 1x12 Monate)Other · Source (Procurement portal) | DAK-GesundheitHamburg | 4 | |
| 6 Jan 2026 | 88fa9ee3-3c6e-4e31-bce5-f8140b2f79fa · Source (Procurement portal) | not in the index | ||
| 6 Jan 2026 | 88fa9ee3-3c6e-4e31-bce5-f8140b2f79fa · Source (Procurement portal) | not in the index | ||
| 1 Dec 2025 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027Other · Source (Procurement portal) | DAK-GesundheitHamburg | 9 | |
| 1 Jul 2025 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate)Other · Source (Procurement portal) | DAK-GesundheitHamburg | 24 | |
| 21 Oct 2024 | Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Orifarm GmbH zu AcarizaxOther · Notice | IKK classicSaxony | 1 | |
| 1 Oct 2024 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2024 - 30.09.2026Other · Source (Procurement portal) | DAK-GesundheitHamburg | 7 | |
| 1 Oct 2024 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 für die Zeit 01.10.2024 - 30.09.2026Other · Source (Procurement portal) | DAK-GesundheitHamburg | 8 | |
| 1 Oct 2024 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2024 - 30.09.2026Other · Source (Procurement portal) | DAK-GesundheitHamburg | 7 | |
| 1 Sep 2024 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026Other · Source (Procurement portal) | DAK-GesundheitHamburg | 18 |
The 20 most recent of 31. All with Pro.
EU-wide awards 2006 to 2023
1,362 awards from 71 contracting authorities, €385,615,663 stated. The most frequent:
Year, contract, contracting authority, value and bids, each award with its source. See everything with Pro
From the EU Official Journal (TED), matched by company key; subsidiaries are not counted. Listed as “Orifarm A/S”, 5.2 bids on average.
Questions and answers
How many public contracts has Orifarm GmbH won?
Orifarm GmbH has received 31 contract awards from public tenders since 2019, most recently on 23 Sep 2026. When the company won, there were 7.8 bids on average. The EU Official Journal also lists 1,362 EU-wide awards between 2006 and 2023.
Which contracting authorities does Orifarm GmbH work for most often?
Most awards came from DAK-Gesundheit (13), Techniker Krankenkasse (3) and IKK classic (2). In total there are 4 contracting authorities.
In which German states is Orifarm GmbH active?
By region of the contract, most awards came from Hamburg (16) and Saxony (2).